D-0341-2026 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0341-2026 was initiated by AvKARE on Feb 13, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Mar 4, 2026
Initiation Date
Feb 13, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-069-15.

Reason for recall

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Distribution pattern

Nationwide in the USA.

Code information

Lot # 49261, Exp: 04/30/27

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0341-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0341-2026. Report a data issue: hello@regdatalab.com.